Skip to content
healthcare.dev

Tizanidine

NDC 76420-865, Tizanidine, tablet, from Asclemed USA, Inc..

Product NDC
76420-865
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076286
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-865 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
76420-865-1276420086512120 TABLET in 1 BOTTLE (76420-865-12)
76420-865-1576420086515150 TABLET in 1 BOTTLE (76420-865-15)
76420-865-307642008653030 TABLET in 1 BOTTLE (76420-865-30)
76420-865-607642008656060 TABLET in 1 BOTTLE (76420-865-60)
76420-865-907642008659090 TABLET in 1 BOTTLE (76420-865-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/81385ce2-1d82-4987-8e18-83c823e10b99

Use it

Look up 76420-865 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-865 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-865. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.